Insulin – Pharmacology, Therapeutic Regimens and Principles of Intensive Insulin Therapy

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  2015-10-12

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel Glucose Sensing Technology And Hypoglycaemia In Type

  2020cited by this paper
• Intensive Treatment and Severe Hypoglycemia Among Adults With Type 2 Diabetes.

  2016cited by this paper
• A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus

  2016cited by this paper
• Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial

  2016cited by this paper
• Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus

  2016cited by this paper
• Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS)

  2015cited by this paper
• New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)

  2015cited by this paper
• New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1)

  2014cited by this paper
• Insulin Analogs—Are They Worth It? Yes!

  2014cited by this paper
• Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association

  2014cited by this paper
• Mechanisms of hypoglycemia-associated autonomic failure in diabetes.

  2013cited by this paper
• Use of Insulin and Insulin Analogs and Risk of Cancer — Systematic Review and Meta-Analysis of Observational Studies

  2013cited by this paper
• Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants

  2013cited by this paper
• The Efficacy and Safety of Insulin Degludec Given in Variable Once-Daily Dosing Intervals Compared With Insulin Glargine and Insulin Degludec Dosed at the Same Time Daily

  2013cited by this paper
• Update on Insulin Therapy for Type 2 Diabetes

  2012cited by this paper
• Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial

  2012cited by this paper
• The pharmacokinetics and pharmacodynamics of rapid‐acting insulin analogues and their clinical consequences

  2012cited by this paper
• Systematic Review and Meta-analysis of Insulin Therapy and Risk of Cancer

  2012cited by this paper
• Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady‐state conditions in type 1 diabetes

  2012cited by this paper
• Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials

  2012cited by this paper
• Glucose-Lowering Effect of Insulin Degludec is Independent of Subcutaneous Injection Region

  2012cited by this paper
• Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data

  2011cited by this paper
• The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial

  2011cited by this paper
• Hypoglycemia and Cardiovascular Risks

  2011cited by this paper
• Premeal Injection of Rapid-Acting Insulin Reduces Postprandial Glycemic Excursions in Type 1 Diabetes

  2010cited by this paper
• The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study

  2010cited by this paper
• Timing of Meal Insulin Boluses to Achieve Optimal Postprandial Glycemic Control in Patients with Type 1 Diabetes

  2010cited by this paper
• Type 2 diabetes mellitus and risk of malignancy: is there a strategy to identify a subphenotype of patients with increased susceptibility to endogenous and exogenous hyperinsulinism?

  2010cited by this paper
• Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial.

  2010cited by this paper
• Hypoglycemia Unawareness in Older Compared With Middle-Aged Patients With Type 2 Diabetes

  2009cited by this paper
• Combined randomised controlled trial experience of malignancies in studies using insulin glargine

  2009cited by this paper
• Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

  2009cited by this paper
• Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study

  2009cited by this paper
• Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

  2009cited by this paper
• Patient‐directed titration for achieving glycaemic goals using a once‐daily basal insulin analogue: an assessment of two different fasting plasma glucose targets ‐ the TITRATETM study

  2009cited by this paper
• Glucose control and vascular complications in veterans with type 2 diabetes.

  2009cited by this paper
• Safety and Efficacy of Inhaled Human Insulin (Exubera) During Discontinuation and Readministration of Therapy in Adults with Type 2 Diabetes: A 3-Year Randomized Controlled Trial

  2009cited by this paper
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2009cited by this paper
• Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

  2009cited by this paper
• Three-year efficacy of complex insulin regimens in type 2 diabetes.

  2009cited by this paper
• Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

  2009cited by this paper
• A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

  2008cited by this paper
• The Barrier of Hypoglycemia in Diabetes

  2008cited by this paper
• Inhaled Technosphere® Insulin in Comparison to Subcutaneous Regular Human Insulin: Time Action Profile and Variability in Subjects with Type 2 Diabetes

  2008cited by this paper
• Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents

  2008cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Reduced Weight Gain with Insulin Detemir Compared to NPH Insulin Is Not Explained by a Reduction in Hypoglycemia

  2008cited by this paper
• Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989

  2007cited by this paper
• Incidence of lipohypertrophy in diabetic patients and a study of influencing factors.

  2007cited by this paper
• Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues

  2007cited by this paper
• Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

  2005cited by this paper
• A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir.

  2005cited by this paper
• Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin.

  2005cited by this paper
• Using new insulin strategies in the outpatient treatment of diabetes: clinical applications.

  2003cited by this paper
• Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.

  2003cited by this paper
• Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart.

  2003cited by this paper
• The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.

  2003cited by this paper
• Intravenous glargine and regular insulin have similar effects on endogenous glucose output and peripheral activation/deactivation kinetic profiles.

  2002cited by this paper
• Insulin pump therapy in the 21st century

  2002cited by this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Insulin Lispro Mixtures

  2002cited by this paper
• Administration of Neutral Protamine Hagedorn Insulin at Bedtime versus with Dinner in Type 1 Diabetes Mellitus To Avoid Nocturnal Hypoglycemia and Improve Control

  2002cited by this paper
• Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.

  2002cited by this paper
• Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring.

  2002cited by this paper
• An overview of insulin glargine

  2002cited by this paper
• Can capillary whole blood glucose and venous plasma glucose measurements be used interchangeably in diagnosis of diabetes mellitus?

  2002cited by this paper
• Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial

  2002cited by this paper
• Diabetes management in the new millennium using insulin pump therapy

  2002cited by this paper
• Post‐prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus

  2001cited by this paper
• Insulin therapy in type 2 diabetes.

  2001cited by this paper
• Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.

  2000cited by this paper
• Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

  2000cited by this paper
• Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

  2000cited by this paper
• Optimising Therapy for Insulin-Treated Type 2 Diabetes Mellitus

  2000cited by this paper
• The use of lispro for high sugar content snacks between meals in intensive insulin regimens

  2000cited by this paper
• Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.

  2000cited by this paper
• Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

  2000cited by this paper
• Type 1 diabetes mellitus and the use of flexible insulin regimens.

  1999cited by this paper
• Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.

  1999cited by this paper
• Meta-Analysis of the Effect of Insulin Lispro on Severe Hypoglycemia in Patients With Type 1 Diabetes

  1998cited by this paper
• Insulin degradation: progress and potential.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Lispro Analog for Treatment of Generalized Allergy to Human Insulin

  1997cited by this paper
• Injection Site Effects on the Pharmacokinetics and Glucodynamics of Insulin Lispro and Regular Insulin

  1996cited by this paper
• Comparison of LysB28, ProB29-Human Insulin Analog and Regular Human Insulin in the Correction of Incidental Hyperglycemia

  1996cited by this paper
• Improved Postprandial Metabolic Control After Subcutaneous Injection of a Short-Acting Insulin Analog in IDDM of Short Duration With Residual Pancreatic β-Cell Function

  1995cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Immunogenicity and Allergenic Potential of Animal and Human Insulins

  1993cited by this paper
• Intensive Insulin Therapy for Treatment of Type I Diabetes

  1990cited by this paper
• The renal metabolism of insulin

  1984cited by this paper
• Intermediate acting insulin given at bedtime: effect on blood glucose concentrations before and after breakfast.

  1983cited by this paper

• Towards the development of an insulin degradation test

  2026cites this paper
• The database of peptide medications for human deep-space missions demonstrates the potential for on-demand “Astropharmacy”

  2026cites this paper
• Impact of structure and formulation changes on the function of insulin products

  2025cites this paper
• Machine Learning-Augmented Analysis of Nano-electrochemical Sensor Data for Predictive and Quantitative Assays of Complex Biological Samples

  2025cites this paper
• From guidelines to practice: an Egyptian expert opinion on type 2 diabetes mellitus management in primary care settings

  2025influential citation
• Navigating Clinical Efficacy and Legal Boundaries: Implications of Nurse-Led Glycemic Management in Critical Care

  2025cites this paper
• Effectiveness of Insulin Versus Oral Agents in Patients with Uncontrolled Type 2 Diabetes Mellitus: A Retrospective Comparative Study

  2025cites this paper
• Evaluation of Glycemia Risk Index and Continuous Glucose Monitoring Outcomes Following the Transition to an Advanced Hybrid Closed-Loop System in Type 1 Diabetes

  2025cites this paper
• Insulin glargine supplementation during early management phase in children with diabetic ketoacidosis: a double-blinded randomised controlled trial

  2025cites this paper
• GZR101, a Novel Premixed Insulin for the Treatment of Diabetes Mellitus

  2025cites this paper
• An Overview of Currently Available Injectable Therapies in Diabetes: A Guide to Practitioners

  2025cites this paper
• Comparative Efficacy and Safety of Basal/Correctional Vs Basal/Bolus/Correctional Insulin Regimens in Medical Intensive Care Unit Patients Receiving Continuous Enteral Nutrition

  2025cites this paper
• Effects of the Part D Senior Savings Model on racial and ethnic disparities in healthcare costs

  2025cites this paper
• Pharmacovigilance Study of Antidiabetic Drugs in Diabetes Mellitus Patients in Three Pharmacies in Yogyakarta

  2025cites this paper
• A Comparison of Glucose and Additional Signals for Three Different Exercise Types in Adolescents with Type 1 Diabetes Using a Hybrid Closed-Loop System

  2025cites this paper
• Strategies for Cardiovascular Disease Prevention in Type 1 Diabetes: A Comprehensive Review

  2024cites this paper
• Comprehensive Management of Pediatric Type 1 Diabetes Mellitus: A Review of Physician, Social Work, and Nursing Roles

  2024cites this paper
• Newer Insulin Preparations and Insulin Analogs

  2024cites this paper
• Comprehensive Review of Pharmacological Therapies and Clinical Guidelines for Diabetes Mellitus: A Depth Study

  2024cites this paper
• Exploring cutting-edge approaches in diabetes care: from nanotechnology to personalized therapeutics

  2024cites this paper
• Icodec: A Novel Once-Weekly Basal Insulin for Diabetes Management

  2024cites this paper
• Subcutaneous fast-acting insulin analogues ± long-acting insulin vs IV insulin infusion in DKA: updated meta-analysis of randomised trials

  2024cites this paper
• Icodec ONWARDS: A review of the first once-weekly diabetes treatment for nurse practitioners and physician assistants

  2024cites this paper
• Advances in Type 1 Diabetes Mellitus Management in Children

  2024cites this paper
• Physiological Effects of Alloxan on Serum Glucose Levels and Liver Function Test in Male Rabbit

  2024cites this paper
• Unmet needs in the treatment of type 1 diabetes: why is it so difficult to achieve an improvement in metabolic control?

  2024cites this paper
• Effects of preprandial versus postprandial nutritional insulin administration in the inpatient setting.

  2024cites this paper
• Persistent Hypoglycemia in Diabetes Type 1 Patient with Medtronic 780 G Insulin Pump: A Case Report

  2024cites this paper
• Prandial Insulins: A Person-Centered Choice

  2024cites this paper
• Dietary supplementation of Lactobacillus brevis SAD ameliorates high-fat diet-induced hyperglycemia and associated metabolic issues in Swiss albino mice

  2024cites this paper
• A Practical Approach to the Initiation, Titration and Intensification of Insulin Therapy in Adults with Diabetes in the Indian Context: Recommendations by Association of Clinical Endocrinologists Consensus Group

  2024cites this paper
• The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review

  2024cites this paper
• Significance and applications of carbon dots in anti cancerous nanodrug conjugate development: A review

  2024cites this paper
• Comparative Study of High-resolution LysB29(Nε-myristoyl) des(B30) Insulin Structures Display Novel Dynamic Causal Interrelations in Monomeric-Dimeric Motions

  2023cites this paper
• Detemir improves diabetic regulation in poorly controlled diabetic dogs with concurrent diseases.

  2023cites this paper
• Various insulin delivery systems for management of diabetes mellitus

  2023cites this paper
• Recovering What Matters: High Protein Recovery after Endotoxin Removal from LPS-Contaminated Formulations Using Novel Anti-Lipid A Antibody Microparticle Conjugates

  2023cites this paper
• Effects of glargine on hyperglycemia in patients with diabetes mellitus type II undergoing off-pump coronary artery bypass graft: A randomized, controlled, double-blind clinical trial

  2023cites this paper
• iGlarLixi provides a higher derived time‐in‐range versus insulin glargine 100 U/mL or lixisenatide in Asian Pacific people with type 2 diabetes: A post hoc analysis

  2023cites this paper
• Local Insulin Improves Wound Healing: A Systematic Review and Bayesian Network Meta-Analysis

  2023cites this paper
• Subcutaneous fast-acting insulin analogues, alone or in combination with long-acting insulin, versus intravenous regular insulin infusion in patients with diabetic ketoacidosis: protocol for an updated systematic review and meta-analysis of randomised trials

  2023cites this paper
• Effectiveness, safety and treatment adherence of biosimilar follow‐on insulin in diabetes management

  2022cites this paper
• Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches

  2022influential citation
• Interval Safety Layer Coupled With an Impulsive MPC for Artificial Pancreas to Handle Intrapatient Variability

  2022cites this paper
• The Cost-Effectiveness Of Intermediate-Acting, Long-Acting, Ultralong-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: A Systematic Review.

  2022cites this paper
• Determination of human insulin and its six therapeutic analogues by capillary electrophoresis - mass spectrometry.

  2022cites this paper
• Giving Insulin Is Not a Guessing Game: Insulin Replacement Therapy in Type 2 Diabetes Mellitus

  2022influential citation
• Challenges in hyperglycemia management in critically ill patients with COVID-19

  2022cites this paper
• Maternal diabetes negatively impacts fetal health

  2022cites this paper
• Ionically cross-linked alginate-chitosan core-shell hydrogel beads for oral delivery of insulin.

  2022cites this paper
• Neutral Protamine Hagedorn versus Glargine 100 International Units among Elderly Patients with Type 2 Diabetes Fasting Ramadan

  2022cites this paper
• A Look Into the Next Century After 100 Years of Insulin

  2022cites this paper
• Pharmacotherapy of type 2 diabetes: An update and future directions.

  2022cites this paper
• World Journal of Critical Care Medicine

  2022cites this paper
• Hypoglycemia in type 2 diabetes

  2021cites this paper
• A Review on the Antidiabetic and Anticancer Activities of Conus Venom Peptides

  2021cites this paper
• A century past the discovery of insulin: global progress and challenges for type 1 diabetes among children and adolescents in low-income and middle-income countries.

  2021cites this paper
• One hundred years since insulin discovery: An update on current and future perspectives for pharmacotherapy of diabetes mellitus

  2021influential citation
• One hundred years of insulin therapy

  2021cites this paper
• The Content of Minerals in the PCOS Group and the Correlation with the Parameters of Metabolism

  2021cites this paper
• The role of microneedle arrays in drug delivery and patient monitoring to prevent diabetes induced fibrosis.

  2021cites this paper
• Expert Group Recommendations on the Effective Use of Bolus Insulin in the Management of Type 2 Diabetes Mellitus

  2021cites this paper
• HYPERGLYCEMIA ON THE BACKGROUND OF TREATMENT OF COVID-19-ASSOCIATED PNEUMONIA USING GLUCOCORTICOIDS

  2021cites this paper
• Challenge of diabetes mellitus and researchers’ contributions to its control

  2021cites this paper
• Diabetes mellitus in der Anästhesie – optimale perioperative Blutzuckerkontrolle

  2021cites this paper
• Cymbopogon citratus (DC.) Stapf mitigates ER-stress induced by streptozotocin in rats via down-regulation of GRP78 and up-regulation of Nrf2 signaling.

  2020cites this paper
• The Role of Gene Therapy in the Treatments of Type 1 Diabetes Mellitus: a review

  2020cites this paper
• Comparison of Analogue insulin with other insulins in patients with type 1 diabetes in Ahmedabad, Western India: A Rretrospective study.

  2020cites this paper
• Adolescent Nutrition: Assuring the Needs of Emerging Adults

  2020cites this paper
• Corticosteroid-related in-hospital hyperglycemia: does it negate mortality benefits in COVID-19?

  2020cites this paper
• Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach

  2020cites this paper
• Nanoparticles-encapsulated polymeric microneedles for transdermal drug delivery.

  2020cites this paper
• Perioperative Management of Systemic Diabetes Mellitus

  2020cites this paper
• Type 1 Diabetes in Youth and Technology-Based Advances in Management.

  2020cites this paper
• Diagnosis, Management, and Dental Considerations for the Diabetic Patient.

  2020cites this paper
• Are newer insulin analogues better for people with Type 1 diabetes?

  2020cites this paper
• BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion

  2019cites this paper
• Transplantation of Autologous Bone Marrow-Derived Stromal Cells in Type 2 Diabetes: A PilotStudy

  2019cites this paper
• ISPITIVANJE LIJEČENJA ŠEĆERNE BOLESTI : USPOREDBA URBANE I RURALNE ORDINACIJE OBITELJSKE MEDICINE

  2019cites this paper
• RSSDI consensus recommendations on insulin therapy in the management of diabetes

  2019cites this paper
• Capacity and confidence building for general practitioners on optimum insulin use

  2019cites this paper
• Improving Type 2 Diabetes Management in General Practice Using a Second-Generation Basal Insulin Analogue Insulin Glargine 300 U/mL: A Practical Guide

  2019cites this paper
• Sugar Works: An Artistic Exploration of Diabetes

  2019cites this paper
• Control of Diabetes Mellitus by Advanced Robust Control Solution

  2019cites this paper
• Combination use of liraglutide and insulin to Japanese patients with multiple insulin injection: efficacy and cost

  2019cites this paper
• Metabolomics and Cell Therapy in Diabetes Mellitus

  2019cites this paper
• Evaluation of the Therapeutic Approach and Outcome of Type 2 Diabetes Mellitus Management Strategies in Cameroon

  2019cites this paper
• Insulin analogs: Glimpse on contemporary facts and future prospective

  2019cites this paper
• EADSG Guidelines: Insulin Storage and Optimisation of Injection Technique in Diabetes Management

  2019cites this paper
• Natural Antioxidant Anthocyanins—A Hidden Therapeutic Candidate in Metabolic Disorders with Major Focus in Neurodegeneration

  2019cites this paper
• Type 1 Diabetes: Management Strategies.

  2018cites this paper
• Switching From Pre-mixed Insulin to Regimens with Insulin Glargine in Type 2 Diabetes: A Prospective, Observational Study of Data From Adriatic Countries

  2018cites this paper
• An overview of insulin therapy in pharmacotherapy of diabetes mellitus type I

  2018cites this paper
• Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability

  2018influential citation
• Practical Approaches to Diagnosing, Treating and Preventing Hypoglycemia in Diabetes

  2017cites this paper
• Pathophysiology and Management of Type 1 Diabetes

  2017cites this paper
• Insulin analogues in type 1 diabetes mellitus: getting better all the time

  2017cites this paper
• World Journal of Diabetes

  year unknowncites this paper
• Insulin Structure and Stability Assessment

  year unknowncites this paper